Yale Study Shows HIV Protease Inhibitors Also Offer Protection Against Malaria

New research from Yale University shows that the use of protease inhibitor-based antiretroviral therapy for HIV is an effective measure for reducing malaria in HIV-infected children in most regions of sub-Saharan Africa. Children with HIV/AIDS in Africa are at a higher-than-average risk for another deadly disease: malaria. But a team of Yale School of Public […]
The post Yale Study Shows HIV Protease Inhibitors Also Offer Protection Against Malaria appeared first on SciTech Daily.